Analyst Information for Clovis Oncology Inc.

$ 5.14   -0.20 (-3.75%) Volume: 7.52m 4:00 PM EDT Sep 18, 2019
After Hours:  $ 5.12   -0.02 (-0.39%) Volume: 2.25m 7:40 PM EDT Sep 18, 2019
Consensus Rating Average
Consensus Rating for CLVS is MODERATE BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 2.00
Previous Average Recommendation 1.89
Change in Average Recommendation 0.11
Number of Analysts Reporting 8
Strong Buy
1.0
Current: 2.00
Previous: 1.89
Change: 0.11
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 372
Rank Recommendation relative to companies in its industry 318
Ranked 318 in Industry
1372 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 4
Analysts recommending Moderate Buy 0
Analysts recommending Hold 4
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 5 5 6
Moderate Buy 0 0 0 0
Hold 4 4 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 1.89 1.57 1.50

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.